22-21855846-A-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002745.5(MAPK1):​c.119+11476T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.343 in 152,124 control chromosomes in the GnomAD database, including 9,608 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9608 hom., cov: 32)

Consequence

MAPK1
NM_002745.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.644

Publications

11 publications found
Variant links:
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
MAPK1 Gene-Disease associations (from GenCC):
  • Noonan syndrome 13
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002745.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK1
NM_002745.5
MANE Select
c.119+11476T>G
intron
N/ANP_002736.3
MAPK1
NM_138957.3
c.119+11476T>G
intron
N/ANP_620407.1Q1HBJ4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK1
ENST00000215832.11
TSL:1 MANE Select
c.119+11476T>G
intron
N/AENSP00000215832.7P28482-1
MAPK1
ENST00000398822.7
TSL:1
c.119+11476T>G
intron
N/AENSP00000381803.3P28482-1
MAPK1
ENST00000544786.1
TSL:1
c.119+11476T>G
intron
N/AENSP00000440842.1P28482-2

Frequencies

GnomAD3 genomes
AF:
0.343
AC:
52113
AN:
152006
Hom.:
9616
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.368
Gnomad ASJ
AF:
0.486
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.331
Gnomad FIN
AF:
0.290
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.421
Gnomad OTH
AF:
0.405
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.343
AC:
52125
AN:
152124
Hom.:
9608
Cov.:
32
AF XY:
0.337
AC XY:
25060
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.219
AC:
9081
AN:
41486
American (AMR)
AF:
0.367
AC:
5618
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.486
AC:
1685
AN:
3470
East Asian (EAS)
AF:
0.210
AC:
1086
AN:
5178
South Asian (SAS)
AF:
0.332
AC:
1599
AN:
4816
European-Finnish (FIN)
AF:
0.290
AC:
3073
AN:
10580
Middle Eastern (MID)
AF:
0.459
AC:
135
AN:
294
European-Non Finnish (NFE)
AF:
0.421
AC:
28607
AN:
67996
Other (OTH)
AF:
0.403
AC:
849
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1720
3440
5160
6880
8600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.256
Hom.:
653
Bravo
AF:
0.343
Asia WGS
AF:
0.255
AC:
888
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
6.8
DANN
Benign
0.54
PhyloP100
0.64
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11913721; hg19: chr22-22210135; API